SOFTWARE COMPARISON
Top 5 Free Covidence Alternatives for Systematic Reviews in 2026
Covidence is a popular systematic review tool, but its pricing (over $339/year per user) and lack of an ongoing free plan make it inaccessible for students, independent researchers, and unfunded research teams. Here is a sourced, honest comparison of the best free alternatives available in 2026.
Published October 12, 2026
Try EvidenceFlow: A truly free Covidence alternative
Private reviews, blind dual screening, extraction, and meta-analysis with no review caps.
1. Comparison Matrix: Free Features vs The Catch
Before committing thousands of citations to a tool, understand where each platform's free limits lie:
| Platform | Free Plan Type | Team & Project Limits | Workflow Scope | Pricing / Upgrade |
|---|---|---|---|---|
| EvidenceFlow | Permanent free core tier | Unlimited reviews & reviewers | Full (Screening + Extraction + Meta-Analysis) | Free forever; optional ₹399/mo AI upgrade |
| Rayyan | Free tier (capped at 3 reviews) | Max 2 collaborators on free tier | Screening focus only (no built-in meta-analysis) | From $4.99/seat/month for extra reviews |
| Sysrev | Permanent free tier (Public only) | Unlimited reviewers | Screening & custom extraction forms | $50/user/month if review must be private |
| RevMan Web | Free for Cochrane authors only | Unlimited for Cochrane teams | Full meta-analysis & Cochrane review authoring | Paid annual license for non-Cochrane reviews |
| Covidence | 500-record trial only | Limited trial collaboration | Screening, extraction, risk of bias | From $339/year per reviewer |
2. In-Depth Breakdown of the Top Alternatives
1. EvidenceFlow (Best for End-to-End Synthesis)
EvidenceFlow offers a connected workflow from literature import (via PubMed or RIS/BibTeX) through title/abstract screening, full-text retrieval, Cochrane RoB 2 appraisal, structured extraction, and built-in meta-analysis (forest plots, $I^2$ statistics). Private projects and team collaboration are included for free without seat limits. Paid upgrades are reserved strictly for AI-assisted screening suggestions rather than locking your data.
2. Rayyan (Best for Screening Only)
Rayyan is well-regarded for fast title and abstract screening. Its free tier allows up to 3 active reviews and 2 collaborators. However, once you complete screening, Rayyan hands you off: you must export your studies to Excel or RevMan to perform data extraction and statistical meta-analysis.
3. Sysrev (Best for Public Open-Science Projects)
Sysrev is a highly customizable document-labeling platform with unlimited reviewers on public projects. However, if your research involves unpublished data, clinical trial registry secrets, or private manuscripts, Sysrev requires a $50/member/month plan to make your project private.
4. RevMan Web (Best for Cochrane Authors)
Cochrane’s RevMan is the gold standard for Cochrane intervention reviews and is completely free for authors registered with Cochrane. However, if you are conducting an independent academic review or a student thesis, non-Cochrane access requires an annual paid license.
3. How to Choose the Right Tool for Your Review
- If you need private reviews, dual screening, extraction, and forest plots in one tool: Choose EvidenceFlow.
- If you only need quick title/abstract screening with 1 colleague: Rayyan is a solid alternative.
- If you are conducting an official Cochrane review: Use Cochrane RevMan.
Get started with EvidenceFlow today
Import your references and experience a modern, free systematic review workflow.
Create Free Account